<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this study, we examined a pediatric case of therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (tMDS) </plain></SENT>
<SENT sid="1" pm="."><plain>The symptoms developed 17 months after treatment for <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, M2 subtype according to the French-American-British [FAB] classification) involving a chromosome abnormality at t(8;21)(q22;q22) </plain></SENT>
<SENT sid="2" pm="."><plain>Upon diagnosis of tMDS, spectral karyotyping analysis detected a new chromosomal translocation at t(2;8)(p23;p11.2) </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, fluorescence in situ hybridization analysis suggested a rearrangement in the monocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> zinc finger (MOZ) gene, located in the 8p11 region of chromosome 8 </plain></SENT>
<SENT sid="4" pm="."><plain>However, no partner gene on 2p23 could be identified </plain></SENT>
<SENT sid="5" pm="."><plain>To our knowledge, this is the first report of tMDS associated with a rearrangement of the MOZ gene </plain></SENT>
<SENT sid="6" pm="."><plain>MOZ-linked fusion proteins such as MOZ-CBP (CREB binding protein), MOZ-TIF2 (transcriptional intermediary factor 2), and MOZ-p300 (adenoviral E1A-associated protein) are associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> chromosomal abnormalities at t(8;16)(p11;p13), inv(8)(p11q13), and t(8;22)(p11;q13), respectively, and are thought to account for <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> occurring through the aberrant regulation of <z:chebi fb="0" ids="15358">histone</z:chebi> acetylation </plain></SENT>
<SENT sid="7" pm="."><plain>Through a similar mechanism, we believe that MOZ, fused to an unidentified partner gene at 2p23, may have caused an alteration in <z:chebi fb="0" ids="15358">histone</z:chebi> acetylation, resulting in the development of tMDS in this patient </plain></SENT>
</text></document>